Insulet Corporation (PODD) PT Lowered to $325 at JPMorgan
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $148.16 +0.88%
Rating Summary:
22 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
22 Buy, 17 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
JPMorgan analyst Robert Marcus lowered the price target on Insulet Corporation (NASDAQ: PODD) to $325.00 (from $365.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Bloom Energy Corporation (NYSE: BE); GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI; CMPO); and Insulet Corporation (NASD
- Netease Inc. (9999:HK) (NTES) PT Lowered to HK$226 at Macquarie
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
